Next-Generation GLP-1 Agents: Safety Profiles and Side Effects You Need to Know
Nov 18 2025
Discover who qualifies for lung cancer screening under new 2023 guidelines. Learn about low-dose CT scans, targeted therapy advances like osimertinib, and how early detection boosts survival rates from 6% to 59%.
Nov 18 2025
Sep 30 2025
Dec 12 2025
Nov 1 2025
Mar 11 2026